Quantcast
Home > Quotes > AMGN
AMGN

Amgen Inc. Common Stock (AMGN) Quote & Summary Data

$194.18
*  
1.73
0.9%
Get AMGN Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading AMGN now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
204
Today's High / Low
$ 195.24 / $ 191.69
Share Volume
3,248,987
50 Day Avg. Daily Volume
2,976,709
Previous Close
$ 192.45
52 Week High / Low
$ 210.19 / $ 163.31
Market Cap
123,735,232,800
P/E Ratio
52.48
Forward P/E (1y)
13.51
Earnings Per Share (EPS)
$ 3.70
Annualized Dividend
$ 5.28
Ex Dividend Date
11/15/2018
Dividend Payment Date
12/7/2018
Current Yield
2.77 %
Beta
0.88

Intraday Chart

Shares Traded

Share Volume:
3,248,987
50 Day Avg. Daily Volume:
2,976,709

P/E Ratio

P/E Ratio:
52.48
Forward P/E (1y):
13.51
Earnings Per Share (EPS):
$ 3.70

Trading Range

The current last sale of $194.18 is 18.90% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 195.24 $ 210.19
 Low: $ 191.69 $ 163.31

ETFs with AMGN as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
9.09% iShares Nasdaq Biotechnology Index Fund (IBB) -5.42 (-4.95%)
8.6% VanEck Vectors Biotech ETF (BBH) +0.03 (0.03%)
5.52% Invesco Dynamic Biotech & Genome ETF (PBE) -4.37 (-7.96%)
5.17% Invesco Dynamic Pharmaceuticals ETF (PJP) +1.07 (1.59%)
3.66% John Hancock Multifactor Healthcare ETF (JHMH) +1.45 (4.49%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Amgen Inc. (including its subsidiaries, referred to as "Amgen," "the Company," "we," "our" or "us") is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  ... More ...  


Risk Grade

Where does AMGN fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 192.36
Open Date:
Nov. 16, 2018
Close Price:
$ 192.45
Close Date:
Nov. 16, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x